Rubius Therapeutics Stock
Rubius is developing a new class of drugs, Red-Cell Therapeutics™,
Sign up today and learn more about Rubius Therapeutics Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Rubius Therapeutics Stock
VentureLabs has been creating breakthrough companies since 2000. It is the first institution dedicated to entrepreneurial innovation, where discovery, invention and entrepreneuring are performed simultaneously by a world-class team of scientists, innovators and professional entrepreneurs. VentureLabs innovates, invents, launches and builds startups through a unique, systematic approach that produces best-in-class companies based on in-house innovations. VentureLabs has started 35 life science and technology companies, including Joule Unlimited, Seres Therapeutics (NASDAQ: MCRB), Pronutria Biosciences, Symbiota and Moderna Therapeutics.
Senior Vice President, Corporate Development
Co-Founder and Chief Innovation Officer
Chief Scientific Officer
Robert J Deans
Torben Straight Nissen